Evidence map›Paper›PMID 32256561›Full record

ArticleNeural plasticity2020

Neuroprotection against Amyloid-

Julien Colas, Natacha Chessel, Allaeddine Ouared, Emmanuelle Gruz-Gibelli, Pascale Marin, François R Herrmann, Armand Savioz

Open access · goldAbstract read
In one paragraph

Article in Neural plasticity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Julien ColasDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0002-7174-8556
Natacha ChesselDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0002-7851-7478
Allaeddine OuaredDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0001-6849-1975
Emmanuelle Gruz-GibelliDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0003-4238-0323
Pascale MarinDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0003-1640-5670
François R HerrmannDepartment of Rehabilitation and Geriatrics, Division of Geriatrics, University Hospital of Geneva and University of Geneva, Geneva, Switzerland.ORCID 0000-0003-1312-1517
Armand SaviozDepartment of Psychiatry, Division of Geriatric Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0001-8059-8281
University Hospital of Geneva · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we have investigated the role of all-

Indexed as

DNA Breaks, Double-StrandedAmyloid beta-PeptidesAnimalsAntioxidantsAstrocytesBrainCell Line, TumorHumansMaleMice, Inbred C57BLNeuronsNeuroprotective AgentsPeptide FragmentsSignal TransductionTretinoinAmyloid beta-Peptidesamyloid beta-protein (1-42)AntioxidantsNeuroprotective AgentsPeptide FragmentsTretinoin

Identifiers

PMID32256561
PMCPMC7109576
OpenAlexW3011219750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.